Tecentriq®
Tecentriq® is a monoclonal antibody that affects the actions of the body’s immune system. It works to strengthen your immune system to help your body fight against tumor cells in non-small cell lung cancer, small cell lung cancer, hepatocellular carcinoma, melanoma, and alveolar soft part sarcoma.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Genentech, Inc. |
CLASS: Programmed Death-Ligand 1 (PD-L1) Inhibitors |
PRESCRIBED BY: Oncologists
|
HOW ADMINISTERED: IV Infusion |
FREQUENCY: Every two-four weeks |
Length of infusion: 60 mins |
FOR MORE INFORMATION: |